Daiichi Sankyo Company, Limited

Japan


 
Total IP 1,879
Total IP incl. subs 2,245 (+ 376 for subs)
Total IP Rank # 681
IP Activity Score 3.6/5.0    779
IP Activity Rank # 923
IP AS incl. subs 3.3/5.0    853
Stock Symbol
ISIN JP3475350009
Market Cap. 4963963256935.5  (JPY)
Industry Drug Manufacturers—General
Sector Healthcare
Dominant Nice Class Pharmaceutical, veterinary and s...

Patents

Trademarks

374 137
199 94
715 281
79
 
Last Patent 2025 - Novel dealkoxyphenylation reaction
First Patent 1986 - Optically active pyridobenzoxazi...
Last Trademark 2024 - ARXATEQ
First Trademark 1962 - TAVANIC

Subsidiaries

16 subsidiaries with IP (339 patents, 37 trademarks)

4 subsidiaries without IP

 Register for free to unlock the subsidiary list

Industry (Nice Classification)

Latest Inventions, Goods, Services

2024 G/S Pharmaceutical preparations and substances; medicines for human purposes.
G/S Pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparat...
G/S Pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for t...
G/S Clinical studies and trials of anticancer drugs; providing information on clinical studies and tr...
G/S Clinical studies and trials of anticancer drugs; providing information on clinical studies and t...
Invention Dosage regimen of an anti-cdh6 antibody-drug conjugate. The present disclosure relates to the fi...
Invention Peptide library and use thereof. Disclosed are compositions and method related to variants of SP...
Invention Anti-cd37 antibody-drug conjugate. It is an object to provide an antibody specifically binding t...
Invention Antibody-drug conjugate. As an antitumor drug which is excellent in terms of antitumor effect an...
Invention Method for producing compound encoded by oligonucleotide, and application thereof. The purpose of...
Invention Griseofulvin compound. An object of the present invention is to provide a compound having an ant...
Invention Stable target editing guide rna having phosphate moiety modification introduced thereinto. Provid...
Invention Method for producing immune cells. Disclosed are a means capable of stably producing TCR-T cells ...
Invention Method for producing mrna. The present invention provides, for example, a method for producing mR...
Invention Method for producing an anti-lag-3 antibody. Provided are methods for producing a monoclonal ant...
G/S Chemicals for industrial purposes, adhesives for industrial purposes not for stationery or househ...
Invention Antibody-drug conjugate production method including purification step using activated carbon mate...
G/S Providing financial assistance to patients in the nature of payment assistance for medications an...
G/S Pharmaceutical preparations for the treatment and prevention of cancer, oncological diseases, leu...
Invention Combination of (anti-her3 antibody)-drug conjugate and rasg12c inhibitor. The present invention p...
Invention Pharmaceutical composition containing mirogabalin. The present invention addresses the problem of...
Invention Klk5 inhibitory peptide. SPINK2 mutant peptide conjugates are provided that inhibit KLK5. The KL...
Invention Anti-sirpa antibody. An anti-SIRPα antibody that can be used as a tumor agent and an anti-tumor ...
Invention Anti-garp antibody. The present invention relates to an antibody that binds to GARP and is usefu...
Invention Novel cyclic dinucleotide derivative and antibody-drug conjugate thereof. Desired is development...
Invention Combination of antibody-drug conjugate and other medicine. The present invention provides: a phar...
Invention Combination of anti-b7-h3 antibody-drug conjugate with atr inhibitor or atm inhibitor. In one emb...
Invention Antibody-pyrrolobenzodiazepine derivative conjugate. The present invention provides a novel anti...
Invention Therapeutic method for low-drug-sensitivity cancers by administration of anti-muc1 antibody-drug ...
Invention Method for producing lentinan. The purpose of the present invention is to provide a method for pr...
Invention Combination of anti-cdh6 antibody-drug conjugate and hif-2a inhibitor. The present invention prov...
Invention Anti-cd25 antibody and anti-cd25 antibody-drug conjugate. The present invention addresses the pro...
Invention Combination of anti-cdh6 antibody-drug conjugate with vegf inhibitor. The present invention provi...
Invention Peptide for treating age-related macular degeneration. It is intended to provide a novel peptide...
Invention Method for producing antibody-drug conjugate. Crystals of the compound represented by formula (1...
Invention Anti-lrrc15 antibody. [Problem] To provide a novel LRRC-15 antibody, or antigen-binding fragment ...
Invention Substituted benzene compound. The present invention addresses the problem of providing a compound...
Invention Griseofulvin compound and pharmaceutical use thereof. The present invention addresses the proble...
Invention Anti-cd37 antibody-drug conjugate. It is an object to provide an antibody specifically binding to...
Invention Peptide for treating retinitis pigmentosa. To provide a novel pharmaceutical use of a peptide. A...
2023 Invention 2-azabicyclo[3.1.1]heptane compound. The problem addressed by the present invention is to provide...
Invention Combination of antibody-drug conjugates and dnmt inhibitors. A pharmaceutical product for adminis...
G/S Conducting of clinical studies and trials of pharmaceuticals for others; providing information on...
G/S Clinical studies and trials of pharmaceuticals; providing information on clinical studies and tr...
Invention Dispiropyrrolidine derivatives. A compound that inhibits interaction between murine double minut...
G/S Pharmaceutical preparations for the treatment and prevention of cardiovascular disease, stroke, d...
G/S Pharmaceutical preparations and substances.
2022 Invention Combination of antibody-drug conjugate and atr inhibitor. A pharmaceutical product for administr...
Invention Protease-cleavable masked antibodies. This invention provides a novel masked antibody. The maske...
Invention Combination of antibody-drug conjugate and parp1 selective inhibitor. A pharmaceutical product f...
Invention Pharmaceutical composition having excellent dissolution properties. The present invention provid...
Invention Methods of treating chemotherapy-resistant cancer with an antibody-drug conjugate. The present d...
Invention Hpv infectious disease vaccine. Provided are lipid particles encapsulating a nucleic acid capabl...
Invention Influenza virus nucleic acid lipid particle vaccine. Provided is a vaccine for preventing and/or...
Invention Htlv-1 nucleic acid lipid particle vaccine. Provided is a vaccine for preventing and/or treating...
Invention Stable multispecific molecule and use thereof. To provide a stable bispecific molecule. To pro...
Invention Gene coding for chimeric receptor for anti-acetylcholine receptor autoantibody. The present inve...
Invention Novel dealkoxyphenylation reaction. To provide a method for obtaining a dealkoxyphenylation prod...
Invention Glycan, and method for producing medicine containing glycan. The present invention addresses the...
2021 Invention A scoring method for an anti-her2 antibody-drug conjugate therapy. A method for predicting how a...
Invention Novel endo-ß-n-acetylglucosaminidase. The present invention provides endo-β-N-acetylglucosaminid...
2020 Invention Combination of anti-garp antibody and immunomodulator. Provided is a pharmaceutical composition ...